There is a change underway in the specialty pharmacy patient experience. First and foremost, the patient and the patient’s direct care team - providers, clinicians and specialists - are focused on putting patient outcomes above anything else. Why? It’s simple: the costs associated with not attaining improved patient outcomes have a domino effect on all players […]
April 1, 2016 – Atlanta, Georgia – One of the nation’s largest independent 340B specialty pharmacies, Curant Health, announces the launch of seven new 340B clinic partnerships beginning April 1, 2016: Columbus Department of Public Health - Ryan White (Columbus, GA) Florida Department of Health in Desoto County - Ryan White (Arcadia, FL) Florida Department […]
The backstory The relationship between medication adherence and wasted healthcare spend is generally uncomplicated in nature; one component can negatively or positively impact the other. In reality, when medication adherence is improved, the amount in wasted healthcare spend long-term is lowered. When news broke recently that $3 billion is wasted on cancer drugs every year […]
March 22, 2016 - Curant COO, Marc O'Connor, in MedCity News - We have long known that improvements in medication adherence are the longest lever available to impact wasteful healthcare spending in the United States. We know further that improvements in adherence affect both variables of the value equation in the right direction: improving outcomes and […]
There are a number of items that influence medication spend, including specialty drug costs, medication adherence and patient outcomes. However, there’s another item out there that may be driving up medication cost unnecessarily. What we know There are 3 well-known drivers that contribute to medication spending in the U.S.: Massive increase in number and cost […]
[vc_row][vc_column][vc_column_text]Curant Health President and CEO, Patrick Dunham, and Curant Health pharmacist, Jeffrey Karkula, RPh, BS Pharm, recently conducted a study to identify the benefits of a comprehensive pharmacy care program and to increase adherence for patients taking highly active antiretroviral therapy or (HAART) and assess the effect on the patient’s overall health outcome. There are […]
March 8, 2016 - Curant COO, Marc O'Connor, in Managed Healthcare Executive - At its simplest, the top three factors impacting medication spending are the massive increases in number and cost of specialty medications, the backlog of generics awaiting FDA approval and lack of medication adherence. According to a recent presentation delivered to the Pharmaceutical […]
There is a spotlight trained on the constant tug of war currently ongoing between payer and manufacturers regarding at-risk negotiations and drug costs. In the background, pharmacists are frequently left solo to handle the prior authorization and to ensure patient access to necessary medication. According to a November 2015 report from The Pew Charitable Trusts, […]
When it comes to treating population health, there is nothing that can replace the value of a real-life, caring person inquiring about a patient’s feelings, opinions and thoughts in order to identify barriers to medication access and adherence. Why is that? The square root of population health is the health of the individual patient. We’ve […]
There were two prevailing topics that dominated this year’s 340B Coalition Winter Conference: mega-guidance and 340B entity audits. While these terms are not mutually exclusive, they each received significant airtime throughout the conference. The mystery of mega-guidance According to 340B Health, mega-guidance (aka omnibus guidance) is a ruling designed to be a ‘one-stop-shop’ of 340B-related […]
